“Warburg may not sell their entire stake if they don’t get the desired valuation. The entire price discovery will be based on the 26% sale, and it will be only secondary. There will be no primary infusion as the company does not need capital now,” a second person said, adding that this will likely be a pre-listing round to set the valuation benchmark. ...